a monoclonal antibody (trade name Remicade) used to treat Crohn's disease and rheumatoid arthritis; administered by infusion; use and dosage must be determined by a physician
an anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis
An immunosuppressive drug (trademark Remicade) administered by intravenous injection especially to treat the symptoms of Crohn's disease, ulcerative colitis, and rheumatoid arthritis. It is a chimeric monoclonal antibody prepared from humans and mice that acts by binding to and blocking the activity of tumor necrosis factor.